Patent ID: 6258852
Filing Date: 2001-07-10
Classification: A61K

Abstract:
A pharmaceutical composition for the treatment or prophylaxis of inflammatory bowel disease comprising a pharmaceutically acceptable carrier and an effective inflammatory bowel disease-treating amount of a compound selected from the group consisting of:N-tert-butyl-.alpha.-(3,5-di-tert-butyl-2-hydroxyphenyl)nitrone,N-isobutyl-.alpha.-phenylnitrone,N-benzyl-.alpha.-(4-acetamidophenyl)nitrone,N-tert-butyl-.alpha.-(1-methylindol-3-yl)nitrone,N-tert-butyl-.alpha.-(3,5-di-tert-butyl-4-acetoxy)nitrone,N-tert-butyl-.alpha.-(4-aminosulfonylphenyl)nitrone,and pharmaceutically acceptable salts thereof.